Checkpoint Therapeutics, Inc. - Common Stock, $0.0001 Par Value (CKPT) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2022 to Q2 2025

Type / Class
Equity / Common Stock, $0.0001 Par Value
Symbol
CKPT on Nasdaq
Shares outstanding
83,070,866
Price per share
$4.16
Price from insider filings
$4.16
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Checkpoint Therapeutics, Inc. - Common Stock, $0.0001 Par Value (CKPT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 5% -50% $17,406,662 -$3,406,953 4,362,572 -16% Armistice Capital, LLC 31 Mar 2025
GLAZER CAPITAL, LLC 3.8% -43% $12,628,350 +$311,013 3,165,000 +2.5% Glazer Capital, LLC 31 Mar 2025

Institutional Holders of Checkpoint Therapeutics, Inc. - Common Stock, $0.0001 Par Value (CKPT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q2 0 $0 -$128,739,852 $4.16 0
2025 Q1 31,915,849 $128,901,911 +$88,225,514 $4.04 83
2024 Q4 11,054,938 $35,390,678 +$10,786,667 $3.20 67
2024 Q3 7,681,837 $17,203,634 +$4,113,873 $2.24 45
2024 Q2 5,866,237 $12,610,112 +$794,876 $2.15 45
2024 Q1 5,383,043 $11,019,342 +$1,271,102 $2.05 38
2023 Q4 4,876,578 $11,166,612 +$2,464,048 $2.29 41
2023 Q3 3,865,516 $6,571,410 +$2,163,810 $1.70 37
2023 Q2 2,574,960 $6,359,785 +$3,151,987 $2.47 32
2023 Q1 1,394,680 $3,137,885 -$3,670,895 $2.25 31
2022 Q4 1,784,212 $9,117,664 +$9,114,399 $5.11 34